The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 117-126

  Ortega, Sterling B ^a   Kashi, Venkatesh P ^a   Tyler, Andrew F ^a   Cunnusamy, Khrishen ^a   Mendoza, Jason P ^a   Karandikar, Nitin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA A ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; WILD TYPE;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA;

EID: 84879634299     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300452     Document Type: Article

References (51)

1. Trapp, B. D., J. Peterson, R. M. Ransohoff, R. Rudick, S. Mo&dierk, and L. Bo&die. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338: 278-285. (Pubitemid 28065253)
2. Raine, C. S., and A. H. Cross. 1989. Axonal dystrophy as a consequence of long-term demyelination. Lab. Invest. 60: 714-725. (Pubitemid 19154520)
3. Keegan, B. M., and J. H. Noseworthy. 2002. Multiple sclerosis. Annu. Rev. Med. 53: 285-302. (Pubitemid 34182821)
4. Stromnes, I. M., and J. M. Goverman. 2006. Passive induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1952-1960. (Pubitemid 46773317)
5. + T cells in early multiple sclerosis. Clin. Immunol. 123: 105-113.
6. Hauser, S. L., A. K. Bhan, F. Gilles, M. Kemp, C. Kerr, and H. L. Weiner. 1986. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19: 578-587. (Pubitemid 16085192)
7. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
8. + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103: 4222-4231.
9. -/- mice. Science 256: 1210-1213.
10. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166: 7579-7587.
11. + T cells in a model for multiple sclerosis. J. Exp. Med. 194: 669-676.
12. + T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35: 76-85.
13. Ji, Q., and J. Goverman. 2007. Experimental autoimmune encephalomyelitis mediated by CD8+T cells. Ann. N. Y. Acad. Sci. 1103: 157-166. (Pubitemid 46791117)
14. + T cells in murine experimental allergic encephalomyelitis. Science 256: 1213-1215.
15. - T cells in an autoimmune disease model. J. Clin. Invest. 112: 1037-1048.
16. Linker, R. A., E. Rott, H. H. Hofstetter, T. Hanke, K. V. Toyka, and R. Gold. 2005. EAE in β-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiol. Dis. 19: 218-228. (Pubitemid 40544739)
17. Beeston, T., T. R. F. Smith, I. Maricic, X. Tang, and V. Kumar. 2010. Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 229: 91-97.
18. + myelin basic protein specific T cells. Autoimmunity 14: 111-119.
19. Hu, D., K. Ikizawa, L. Lu, M. E. Sanchirico, M. L. Shinohara, and H. Cantor. 2004. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5: 516-523. (Pubitemid 38660464)
20. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 98: 6301-6306.
21. + T cells for sustained CNS inflammation during chronic EAE. J. Neuroimmunol. 213: 60-68.
22. + T and B cells. J. Immunol. 188: 2084-2092.
23. + T cells in experimental autoimmune encephalomyelitis. J. Autoimmun. 35: 33-44.
24. + regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. J. Autoimmun. 36: 115-124.
25. + T-cells in multiple sclerosis. J. Neuroimmunol. 234: 131-140.
26. + T cells in multiple sclerosis. J. Immunol. 176: 7119-7129.
27. + Tregs. J. Clin. Invest. 116: 2434-2441.
28. + regulatory T cells suppress experimental autoimmune encephalomyelitis by TGF-β- and IFN-γ-dependent mechanisms. Eur. J. Immunol. 39: 3423-3435.
29. + T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. Int. Immunol. 23: 751-759.
30. + effector memory T cells in vivo. Blood 118: 3890-3900.
31. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
32. +) T cell responses in patients with multiple sclerosis. J. Clin. Invest. 109: 641-649.
33. + regulatory T cells in patients with primary antiphospholipid syndrome. J. Clin. Immunol. 33: 876-879.
34. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Ba&dieckstro&diem, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431. (Pubitemid 46559831)
35. + T cells to retinoic acid and TGFβ in systemic lupus erythematosus. Arthritis Res. Ther. 13: R106.
36. + regulatory T cells in systemic autoimmune diseases. Autoimmun. Rev. 10: 744-755.
37. low regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS ONE 7: e34662.
38. + T cells expressing dual TCRs. Nat. Immunol. 11: 628-634.
39. Mars, L. T., J. Bauer, D. A. Gross, F. Bucciarelli, H. Firat, D. Hudrisier, F. Lemonnier, K. Kosmatopoulos, and R. S. Liblau. 2007. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J. Immunol. 179: 5090-5098.
40. Na, S.-Y., Y. Cao, C. Toben, L. Nitschke, C. Stadelmann, R. Gold, A. Schimpl, and T. Hünig. 2008. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 131: 2353-2365.
41. Saxena, A., J. Bauer, T. Scheikl, J. Zappulla, M. Audebert, S. Desbois, A. Waisman, H. Lassmann, R. S. Liblau, and L. T. Mars. 2008. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181: 1617-1621.
42. Zhang, J., R. Medaer, P. Stinissen, D. Hafler, and J. Raus. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261: 1451-1454. (Pubitemid 23334267)
43. Volovitz, I., Y. Marmor, F. Mor, A. Flügel, F. Odoardi, L. Eisenbach, and I. R. Cohen. 2010. T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells. J. Autoimmun. 35: 135-144.
44. Tsai, S., A. Shameli, J. Yamanouchi, X. Clemente-Casares, J. Wang, P. Serra, Y. Yang, Z.Medarova, A. Moore, and P. Santamaria. 2010. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32: 568-580.
45. Elong Ngono, A., S. Pettré, M. Salou, B. Bahbouhi, J.-P. Soulillou, S. Brouard, and D.-A. Laplaud. 2012. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients. Clin. Immunol. 144: 117-126.
46. Hudrisier, D., A. Aucher, A.-L. Puaux, C. Bordier, and E. Joly. 2007. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells. J. Immunol. 178: 3637-3647. (Pubitemid 46417631)
47. Hudrisier, D., J. Riond, L. Garidou, C. Duthoit, and E. Joly. 2005. T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells. Eur. J. Immunol. 35: 2284-2294. (Pubitemid 41179749)
48. + T helper-antigen-presenting cells. J. Immunol. 174: 7497-7505.
49. + T cell responses. J. Immunol. 182: 193-206.
50. Jürgens, B., U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger. 2009. Interferon-γ-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 114: 3235-3243.
51. Martini, M., M. G. Testi, M. Pasetto, M. C. Picchio, G. Innamorati, M. Mazzocco, S. Ugel, S. Cingarlini, V. Bronte, P. Zanovello, et al. 2010. IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine 28: 3548-3557.